C110P: Tanezumab Biosimilar, NGF Monoclonal Antibody
Recombinant Humanized IgG2 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade tanezumab biosimilar specifically binds to the NGF protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tanezumab.C108P: Rovalpituzumab Biosimilar, DLL3 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade rovalpituzumab biosimilar specifically binds to the DLL3 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by rovalpituzumab.C065P: Volociximab Biosimilar (Research Grade), Anti-human Integrin α5β1 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade volociximab biosimilar specifically binds to the human integrin α5β1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by volociximab.C060P: Pateclizumab Biosimilar (Research Grade), Anti-human Lymphotoxin Alpha (LT-α) Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade pateclizumab biosimilar specifically binds to the human lymphotoxin alpha (LT-α).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by pateclizumab.PA007525.m2a: In Vivo Grade Recombinant Anti-mouse NK1.1 Monoclonal Antibody (Clone: PK136), Mouse IgG2a Kappa
Recombinant mouse IgG2a Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: PK136) specifically binds to mouse NK1.1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse NK1.1 protein.PA007548.m2a: In Vivo Grade Recombinant Anti-rat Kappa Light Chain Monoclonal Antibody (Clone: MAR18.5), Mouse IgG2a Kappa
Recombinant Mouse IgG2a Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: MAR18.5) specifically binds to rat Kappa Light Chain.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the rat Kappa Light Chain protein.C109P: Tusamitamab Biosimilar, CEACAM5 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade tusamitamab biosimilar specifically binds to the CEACAM5 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tusamitamab.C052P: Polatuzumab Biosimilar, CD79B Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade polatuzumab biosimilar specifically binds to the CD79B protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by polatuzumab.C106P: Ifinatamab Biosimilar, B7-H3 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade ifinatamab biosimilar specifically binds to the human B7-H3 (CD276) protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ifinatamab.C105P: Evolocumab Biosimilar, PCSK9 Monoclonal Antibody
Recombinant fully human IgG2 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody evolocumab biosimilar specifically binds to the human PCSK9.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by evolocumab.